Appendix 3B - Proposed issue of securities Announcement Summary Entity name THE HYDRATION PHARMACEUTICALS COMPANY LIMITED Announcement Type New announcement Date of this announcement 23/10/2026 The Proposed issue is: A standard pro rata issue (including non-renounceable or renounceable) Total...
Proposed issue of securities - HPC
Filed with ASX ·
6ix hasn’t read this filing yet.
Hydration Pharmaceuticals Company Limited on 6ix
Earlier from Hydration Pharmaceuticals
- Letter to UMP Shareholders and Retention Form
- Prospectus - Non Renounceable Rights Issue
- Rights Issue and UMP Share Sale Facility
- Results of Extraordinary General Meeting
- July and August 2026 Trading Update
Later from Hydration Pharmaceuticals
- Change in substantial holding
- Becoming a substantial holder
- Q3 FY26 Quarterly Activities Report (App 4C)
- Rights Offer - Despatch of Prospectus
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals